Updated Jul 16, 2026
GROVES REGINA E has filed 2 SEC Form 4 filings across 2 companies in the last 90 days — selling. Lifetime open-market sales: $90K.

| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-20 | ATRC | AtriCure, Inc. | A — Grant or award | 6.1K | $0.00 | |
| 2026-05-18 | FLGT | Fulgent Genetics, Inc. | A — Grant or award | 11.1K | $0.00 | |
| 2025-08-06 | ATRC | AtriCure, Inc. | S — Open-market sale | 2.5K | $36.82 | $90K |
GROVES REGINA E is a corporate insider — currently tracked as Director of AtriCure, Inc. (ATRC). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($90K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live GROVES REGINA E profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.